[{"@context":"https:\/\/schema.org\/","@type":"Article","@id":"https:\/\/www.rizklaw.com\/belviq-lawsuit\/#Article","mainEntityOfPage":"https:\/\/www.rizklaw.com\/belviq-lawsuit\/","headline":"Belviq","name":"Belviq","description":"Lorcaserin, a drug marketed under the brand name Belviq, is a medication intended to help adults suffering from medical issues due to obesity or excess weight lose weight and prevent them from gaining it back. However, in February of 2020, the\u00a0U.S. Food and Drug Administration (FDA)\u00a0requested that the manufacturer of Belviq and Belviq XR withdraw...","datePublished":"2024-04-11","dateModified":"2026-04-18","author":{"@type":"Person","@id":"https:\/\/www.rizklaw.com\/blog\/author\/rizklaw\/#Person","name":"Rizk Law","url":"https:\/\/www.rizklaw.com\/blog\/author\/rizklaw\/","identifier":9,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/10e23ce5e6c4dadb4589cd8edf2c3f59ac356a6e876c3656917777913d9c3bc1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/10e23ce5e6c4dadb4589cd8edf2c3f59ac356a6e876c3656917777913d9c3bc1?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Rizk Law","logo":{"@type":"ImageObject","@id":"https:\/\/www.rizklaw.com\/wp-content\/uploads\/2024\/03\/rizk-law-logo-footer.jpg","url":"https:\/\/www.rizklaw.com\/wp-content\/uploads\/2024\/03\/rizk-law-logo-footer.jpg","width":278,"height":65}},"image":{"@type":"ImageObject","@id":"https:\/\/www.rizklaw.com\/wp-content\/uploads\/2024\/05\/belviq-lawsuit.jpg","url":"https:\/\/www.rizklaw.com\/wp-content\/uploads\/2024\/05\/belviq-lawsuit.jpg","height":282,"width":915},"url":"https:\/\/www.rizklaw.com\/belviq-lawsuit\/"},{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","@id":"https:\/\/www.rizklaw.com\/belviq-lawsuit\/#BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Belviq","item":"https:\/\/www.rizklaw.com\/belviq-lawsuit\/#breadcrumbitem"}]}]